An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV)
Copyright © 2016. Published by Elsevier Ltd..
Infectious bursal disease virus (IBDV) causes immunosuppression in young chickens, leading to increased susceptibility to other diseases and a reduction in the immune response to other vaccines. Thus, IBDV results in great economic losses to the poultry industry. The most effective method of prevention is vaccination. However, medium-virulence vaccines can cause bursal pathological damage and immunosuppression. Here, we describe a safer, self-assembled, subvirus-like particle (sVP) vaccine without a complex purification process. The IBD-VP2 gene was cloned into Pichia pastoris, and the expressed protein self-assembled into T=1 sVPs (∼23nm). Immunization experiments showed that the sVP vaccine elicited high IBDV-neutralizing antibodies in each group, and all birds survived challenge with very virulent IBDV (vvIBDV). Additionally, IBDV RNA was not detected, and sterile immunity was achieved. In conclusion, the IBD-sVP is a suitable candidate for a recombinant subunit vaccine against IBDV.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
Vaccine - 34(2016), 30 vom: 24. Juni, Seite 3508-14 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wang, Miao [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.10.2017 Date Revised 04.12.2017 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.vaccine.2016.02.072 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM260208582 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM260208582 | ||
003 | DE-627 | ||
005 | 20231224192910.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2016.02.072 |2 doi | |
028 | 5 | 2 | |a pubmed24n0867.xml |
035 | |a (DE-627)NLM260208582 | ||
035 | |a (NLM)27164218 | ||
035 | |a (PII)S0264-410X(16)00277-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wang, Miao |e verfasserin |4 aut | |
245 | 1 | 3 | |a An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV) |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.10.2017 | ||
500 | |a Date Revised 04.12.2017 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016. Published by Elsevier Ltd. | ||
520 | |a Infectious bursal disease virus (IBDV) causes immunosuppression in young chickens, leading to increased susceptibility to other diseases and a reduction in the immune response to other vaccines. Thus, IBDV results in great economic losses to the poultry industry. The most effective method of prevention is vaccination. However, medium-virulence vaccines can cause bursal pathological damage and immunosuppression. Here, we describe a safer, self-assembled, subvirus-like particle (sVP) vaccine without a complex purification process. The IBD-VP2 gene was cloned into Pichia pastoris, and the expressed protein self-assembled into T=1 sVPs (∼23nm). Immunization experiments showed that the sVP vaccine elicited high IBDV-neutralizing antibodies in each group, and all birds survived challenge with very virulent IBDV (vvIBDV). Additionally, IBDV RNA was not detected, and sterile immunity was achieved. In conclusion, the IBD-sVP is a suitable candidate for a recombinant subunit vaccine against IBDV | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Infectious bursal disease virus | |
650 | 4 | |a Yeast | |
650 | 4 | |a sVP | |
650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a VP2 protein, infectious bursal disease virus |2 NLM | |
650 | 7 | |a Vaccines, Subunit |2 NLM | |
650 | 7 | |a Vaccines, Synthetic |2 NLM | |
650 | 7 | |a Vaccines, Virus-Like Particle |2 NLM | |
650 | 7 | |a Viral Structural Proteins |2 NLM | |
650 | 7 | |a Viral Vaccines |2 NLM | |
700 | 1 | |a Pan, Qing |e verfasserin |4 aut | |
700 | 1 | |a Lu, Zhen |e verfasserin |4 aut | |
700 | 1 | |a Li, Kai |e verfasserin |4 aut | |
700 | 1 | |a Gao, Honglei |e verfasserin |4 aut | |
700 | 1 | |a Qi, Xiaole |e verfasserin |4 aut | |
700 | 1 | |a Gao, Yulong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiaomei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Vaccine |d 1985 |g 34(2016), 30 vom: 24. Juni, Seite 3508-14 |w (DE-627)NLM012600105 |x 1873-2518 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2016 |g number:30 |g day:24 |g month:06 |g pages:3508-14 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.vaccine.2016.02.072 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2016 |e 30 |b 24 |c 06 |h 3508-14 |